Letters in Drug Design & Discovery

2.2k papers and 13.2k indexed citations i.

About

The 2.2k papers published in Letters in Drug Design & Discovery in the last decades have received a total of 13.2k indexed citations. Papers published in Letters in Drug Design & Discovery usually cover Organic Chemistry (1.2k papers), Molecular Biology (733 papers) and Computational Theory and Mathematics (366 papers) specifically the topics of Synthesis and biological activity (793 papers), Synthesis and Characterization of Heterocyclic Compounds (405 papers) and Computational Drug Discovery Methods (366 papers). The most active scholars publishing in Letters in Drug Design & Discovery are Xing‐Hai Liu, M. Iqbal Choudhary, David C. Swinney, Ahmet Özdemır, Mehlika Dilek Altıntop, Khalid Mohammed Khan, Jian‐Quan Weng, Cheng‐Xia Tan, Matthias Tacke and Gary Gellerman.

In The Last Decade

Fields of papers published in Letters in Drug Design & Discovery

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Letters in Drug Design & Discovery. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Letters in Drug Design & Discovery

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Letters in Drug Design & Discovery. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Letters in Drug Design & Discovery with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025